NewsRoom Articles - Page 160 of 606

WednesdayOct 12, 2022 4:20 am

420 with CNW — An Analysis of Current Marijuana Users within the US

Cannabis has been one of the most-used drugs in the United States and the world at large for decades. Despite being prohibited until the early 2000s, cannabis had enjoyed top status as an extremely popular drug amid extremely strict policing and harsh sentencing. Now that dozens of U.S. states and territories have launched legal cannabis markets, access to cannabis among Americans has increased exponentially. These days, cannabis is consumed in demographics that you would never even think of just a decade or two ago. While there’s a significant chance the person standing next to you at a concert is high,…

TuesdayOct 11, 2022 4:20 pm

420 with CNW — Despite Regulatory Lacuna, CBD Foods and Drinks Are Growing in Popularity

Cannabidiol (CBD) is a chemical compound largely produced by hemp, a plant from the cannabis family. However, unlike the marijuana plant, hemp is not intoxicating because it usually contains little to no levels of the psychotropic compound delta-9 tetrahydrocannabinol (THC). CBD’s main claim to fame is that it is said to have potent medical properties. Initial studies have found that the compound may be able to alleviate chronic pain, anxiety and insomnia, among other things. Cannabidiol has grown exceedingly popular in recent years due to its purported medical benefits coupled with the fact that it can be consumed in a…

TuesdayOct 11, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented DehydraTECH(TM) Technology Offering Solutions to Growing Hypertension Problem Worldwide

Hypertension affects nearly half of all adults in the United States – 47% or 116 million people, some of which are medication-resistant A recent study from the University of Toledo College of Medicine and Life Sciences concluded gut bacteria might be the cause of medication-resistant hypertension – as demonstrated in rats used to conduct the study Lexaria’s patented DehydraTECH(TM) technology offers a viable solution for hypertension drug administration and has been received favorably by the FDA during a pre-Investigational New Drug meeting Hypertension, or high blood pressure, remains one of the world’s most deadly health problems, considered a silent killer…

TuesdayOct 11, 2022 4:20 am

420 with CNW — Most Americans Don’t Believe Propaganda About Marijuana’s Purported Dangers

For the millions of Americans who grew up under the prohibitionist era, cannabis was presented as a dangerous gateway drug that significantly contributed to drug abuse and criminal activity. Anti-cannabis propaganda was rife during this period, with prohibitionists assigning a wide range of negative effects to cannabis use despite the fact that there was barely any scientific research into the matter. Decades later, tens of millions of Americans now have access to the drug through state-legal markets. Attitudes toward the drug have changed over the past two decades, especially among younger generations, and more people believe that cannabis has more…

MondayOct 10, 2022 4:20 pm

420 with CNW — Bill on Illicit Cannabis Grows, Banned Pesticides Filed in Congress

Illicit cannabis operators have raked in big bucks over the past couple of decades despite strict prohibitionist laws. By 2019, the illicit market in California, the largest cannabis market in America, was worth an estimated $8.7 billion. Even as more states legalize recreational cannabis use and dozens launch medical cannabis markets, the illicit market has proven to be too tough an opponent to beat. Most of the cannabis sales in America are still underground, funding an illicit billion-dollar industry that significantly contributes to water waste and harms the environment. Black market sales also deny states tax revenue and funnel cash…

MondayOct 10, 2022 11:15 am

Rosy Outlook for Global Cannabis Market Boosts Hopes for Flora Growth Corp. (NASDAQ: FLGC) as Supply Chain Expands

Cannabis grower and product maker Flora Growth is developing its own approach to riding troubling economic forces, boasting a 604 percent YOY increase in the H1 reporting period this year Market analysts predict the global cannabis market’s value will rise during the next five years at a CAGR of 24.3 percent to arrive at annual valuation of $82.3 billion Flora Growth is levying the potential of recent cooperative agreements to increase the reach of its product distribution pipeline, including new exports to Switzerland, the Czech Republic and the United States Europe is predicted to be the fastest-growing region for cannabis…

MondayOct 10, 2022 4:20 am

420 with CNW — Hurricane Ian Forces Closure of Cannabis Businesses in Florida

Hurricane Ian has left structural damage and destruction in its wake, with more than 100 cannabis businesses in Florida being forced to close. Data from the National Hurricane Center and the Florida Office of Medical Marijuana Use show that over one-half of the medical cannabis stores in the state of Florida are located in the direct path of the potential storm surges and excessive rainfall. Some of the medical cannabis retailers operating in the state have been providing updates on closures via social media as well as through their websites. This includes Liberty Health Sciences, which closed 39 of its…

FridayOct 07, 2022 4:20 pm

420 with CNW — Cannabis M&A Activity Slows Down, Industry Isn’t Worried

Decades after Congress passed prohibitionist policies that outlawed the cultivation, sale and consumption of marijuana, dozens of states now allow their residents to use medical marijuana. America’s medical cannabis market currently has more than 3.5 million registered patients and is projected to be worth $248 billion by 2030. Last year was historic for the medical cannabis market in terms of mergers and acquisitions (M&A), with Viridian Capital Advisors from New York tracking 306 such transactions throughout the year compared to 86 in 2020. Experts and industry insiders predicted that 2022 would be an even greater year for M&A transactions. MJBiz…

FridayOct 07, 2022 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Working to Address Declining Antihypertensive Intensification and High Prescription Abandonment Rates, with DehydraTECH-CBD

Lexaria is a global innovator in drug delivery platforms developing DehydraTECH-CBD as a potential treatment for hypertension A 2022 study documented a decline in the percentage of patients receiving appropriate treatment intensification over the last ten years This decline has been attributed to, among other possible reasons, the side effects of antihypertensive drugs At the same time, only 24% of adults with hypertension have the condition under control, a statistic attributable to the medications’ troublesome side effects Lexaria’s investigations of its DehydraTECH-CBD have so far presented favorable safety and tolerability data, meaning its drug candidate could offer reprieve to millions…

FridayOct 07, 2022 4:20 am

420 with CNW — USDA Report Highlights Environmental, Economic Benefits of Hemp as EU Market Grows

In August, the U.S. Department of Agriculture released a report on the hemp industry boom in the European Union. The report recognized that hemp was an important commodity that could aid the European Union in achieving its climate-related objectives. The report also discusses how the cannabis crop has been cultivated and utilized in the region for millennia and how products from the crop are now increasing in popularity, as more nations enact decriminalization reforms. The report states that since the Middle Age, all parts of the hemp plant were consumed in European nations, including its flowers, leaves and seeds as…